BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sava F, Perrault H, Brouillard C, Darauay C, Hamilton A, Bourbeau J, Maltais F. Detecting improvements in dyspnea in COPD using a three-minute constant rate shuttle walking protocol. COPD 2012;9:395-400. [PMID: 22509905 DOI: 10.3109/15412555.2012.674164] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Wu W, Jing M, Lu G, Hong H, Shao X, Rui L. Effect of Oxygen-driven Nebulization at Different Oxygen Flows in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients. The American Journal of the Medical Sciences 2014;347:343-6. [DOI: 10.1097/maj.0b013e3182937766] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Beaulieu J, Jensen D, O'Donnell DE, Brouillard C, Tracey L, Vincent S, Nadreau É, Bernard E, Bernard S, Maltais F. Relieving exertional dyspnea during the 3-min constant speed shuttle test in patients with COPD with indacaterol/glycopyrronium versus tiotropium: the RED trial. Ther Adv Respir Dis 2020;14:1753466620939507. [PMID: 32663102 DOI: 10.1177/1753466620939507] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Adachi D, Nishiguchi S, Fukutani N, Kayama H, Tanigawa T, Yukutake T, Hotta T, Tashiro Y, Morino S, Yamada M, Aoyama T. Factors associating with shuttle walking test results in community-dwelling elderly people. Aging Clin Exp Res 2015;27:829-34. [PMID: 25749887 DOI: 10.1007/s40520-015-0342-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
4 Borel B, Provencher S, Saey D, Maltais F. Responsiveness of Various Exercise-Testing Protocols to Therapeutic Interventions in COPD. Pulm Med 2013;2013:410748. [PMID: 23431439 DOI: 10.1155/2013/410748] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
5 Lewthwaite H, Koch EM, Tracey L, Jensen D. Standardized measurement of breathlessness during exercise. Curr Opin Support Palliat Care 2019;13:152-60. [PMID: 31268873 DOI: 10.1097/SPC.0000000000000443] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
6 Maltais F, Aumann JL, Kirsten AM, Nadreau É, Macesic H, Jin X, Hamilton A, O'Donnell DE. Dual bronchodilation with tiotropium/olodaterol further reduces activity-related breathlessness versus tiotropium alone in COPD. Eur Respir J 2019;53:1802049. [PMID: 30655277 DOI: 10.1183/13993003.02049-2018] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 7.3] [Reference Citation Analysis]
7 Aitken CR, Sharma P, Louis M, Walsh J, Stewart GM, Sabapathy S, Adams L, Morris NR. Examining the repeatability of a novel test to measure exertional dyspnoea in chronic obstructive pulmonary disease. Respir Physiol Neurobiol 2021;296:103826. [PMID: 34864520 DOI: 10.1016/j.resp.2021.103826] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Johnston KN, Potter AJ, Phillips A. Measurement Properties of Short Lower Extremity Functional Exercise Tests in People With Chronic Obstructive Pulmonary Disease: Systematic Review. Phys Ther 2017;97:926-43. [PMID: 28605481 DOI: 10.1093/ptj/pzx063] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
9 Borel B, Wilkinson-Maitland CA, Hamilton A, Bourbeau J, Perrault H, Jensen D, Maltais F. Three-minute constant rate step test for detecting exertional dyspnea relief after bronchodilation in COPD. Int J Chron Obstruct Pulmon Dis 2016;11:2991-3000. [PMID: 27942208 DOI: 10.2147/COPD.S113113] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
10 Ekström M, Elmberg V, Lindow T, Wollmer P. Breathlessness measurement should be standardised for the level of exertion. Eur Respir J 2018;51:1800486. [DOI: 10.1183/13993003.00486-2018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
11 Ekström M. Why treatment efficacy on breathlessness in laboratory but not daily life trials? The importance of standardized exertion. Curr Opin Support Palliat Care 2019;13:179-83. [PMID: 31246594 DOI: 10.1097/SPC.0000000000000444] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
12 Lewthwaite H, Koch EM, Ekström M, Hamilton A, Bourbeau J, Maltais F, Borel B, Jensen D. Predicting the rate of oxygen consumption during the 3-minute constant-rate stair stepping and shuttle tests in people with chronic obstructive pulmonary disease. J Thorac Dis 2020;12:2489-98. [PMID: 32642156 DOI: 10.21037/jtd.2020.03.13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Maltais F, de la Hoz A, Casaburi R, O'Donnell D. Effects of Tiotropium/Olodaterol on Activity-Related Breathlessness, Exercise Endurance and Physical Activity in Patients with COPD: Narrative Review with Meta-/Pooled Analyses. Adv Ther 2021;38:835-53. [PMID: 33306188 DOI: 10.1007/s12325-020-01557-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]